[Table/Fig-9]:
Overall comparison of control and treatment group.
| Parameters | Post-op day | Control (n=30) |
Treatment (n=30) |
p-value | Absolute risk reduction# |
Risk Ratio |
|---|---|---|---|---|---|---|
| Pain | 3rd day | 18(60.0%) | 6(20.0%) | 0.002** | 0.40 | 0.33 |
| 7th day | 12(40.0%) | 5(16.7%) | 0.045* | 0.23 | 0.42 | |
| 14th day | 9(30.0%) | 2(6.7%) | 0.020* | 0.23 | 0.22 | |
| Dist. of clot$ | 3rd day | 3(10.0%) | 3(10.0%) | 1.000 | - | 1.00 |
| 7th day | 3(10.0%) | 2(6.7%) | 1.000 | 0.03 | 0.67 | |
| 14th day | 2(6.7%) | 0 | 0.492 | - | - | |
| Halitosis | 3rd day | 3(10.0%) | 2(6.7%) | 1.000 | 0.03 | 0.67 |
| 7th day | 3(10.0%) | 1(3.3%) | 0.612 | 0.07 | 0.33 | |
| 14th day | 2(6.7%) | 0 | 0.492 | - | - |
# Percentage of absolute risk reduction of treatment when compared to control
$Disintegration of clot
Risk ratio <1: Less likely of risk in treatment
Risk Ratio>1: More likely of risk in treatment
Risk ratio=1 Equally likely between two groups
*significant
**Highly significant